|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2003-3-21
|
|
pubmed:abstractText |
This prospective phase II trial was performed to determine the efficacy and toxicity of mitomycin C, vinorelbine and cisplatin combination chemotherapy for patients with previously untreated stage IIIB or IV non-small cell lung cancer (NSCLC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1226-3303
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
240-4
|
|
pubmed:dateRevised |
2006-9-26
|
|
pubmed:meshHeading |
pubmed-meshheading:12647638-Adult,
pubmed-meshheading:12647638-Aged,
pubmed-meshheading:12647638-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12647638-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:12647638-Cisplatin,
pubmed-meshheading:12647638-Dose-Response Relationship, Drug,
pubmed-meshheading:12647638-Female,
pubmed-meshheading:12647638-Humans,
pubmed-meshheading:12647638-Lung Neoplasms,
pubmed-meshheading:12647638-Male,
pubmed-meshheading:12647638-Middle Aged,
pubmed-meshheading:12647638-Mitomycin,
pubmed-meshheading:12647638-Treatment Outcome,
pubmed-meshheading:12647638-Vinblastine
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
A phase II study of vinorelbine, mitomycin C and cisplatin chemotherapy for advanced non-small cell lung cancer.
|
|
pubmed:affiliation |
Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea. tufmr@hanmail.net
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
